These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 844105)

  • 1. [Stimulating action of a combination of oestradiol with 17alpha-hydroxyprogesterone-capronate upon the LH elimination in women with stein-leventhal syndrome clinically diagnosed (author's transl)].
    Divila F; Presl J; Stroufová A
    Cesk Gynekol; 1977 Feb; 42(1):11-4. PubMed ID: 844105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
    Nillius SJ; Bergquist C; Wide L
    Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immobilization does not inhibit the post-coital ovulatory surge of luteinizing hormone in the rabbit.
    YoungLai EV; Dimond P
    Neuroendocrinology; 1976; 20(4):352-7. PubMed ID: 967303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle.
    Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR
    J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma norepinephrine during the rat estrous cycle and after progesterone treatment to the ovariectomized estrogen-primed rat.
    Nagle CA; Rosner JM
    Neuroendocrinology; 1976; 22(1):89-96. PubMed ID: 1035969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
    Lachelin GC; Yen SS
    J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
    Schwartz NB
    Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of luteinizing hormone-releasing factor (lrf) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat.
    Moss RL; McCann SM
    Neuroendocrinology; 1975; 17(4):309-18. PubMed ID: 806824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N; Olivier GC
    Horm Res; 1978; 9(1):12-21. PubMed ID: 338460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doses-related effects of lynestrenol on ovulation (author's transl)].
    Pizarro MA; Thomas K; Ferin J
    Reproduccion; 1976; 3(3-4):193-205. PubMed ID: 802117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
    Schally AV
    Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.